SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Filing Date
Dec 20, 2013
Document Date
Dec 20, 2013
Form Description
Written public communication relating to an issuer or third party tender offer
Filing Group
Mergers & Acquisitions
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC